Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

DARE holding history

Dare Bioscience, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DARE overviewAll 13F holders of DAREFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of DARE by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−16,735−100.0%Sold outHolders
Q2 202516,735$40.0K<0.1%+50+0.3%AddedHolders
Q1 202516,685$48.0K<0.1%+50+0.3%AddedHolders
Q4 202416,635$52.0K<0.1%−851−4.9%ReducedHolders
Q3 202417,486$57.0K<0.1%+13,659+356.9%AddedConverted for a 1-for-12 splitHolders
Q2 202445,925$15.0K<0.1%00.0%UnchangedHolders
Q1 202445,925$23.0K<0.1%+13,300+40.8%AddedHolders
Q4 202332,625$10.0K<0.1%−16,704−33.9%ReducedHolders
Q3 202349,329$23.0K<0.1%−250−0.5%ReducedHolders
Q2 202349,579$45.0K<0.1%−3,000−5.7%ReducedHolders
Q1 202352,579$54.0K<0.1%+9,000+20.7%AddedHolders
Q4 202243,579$36.0K<0.1%00.0%UnchangedHolders
Q3 202243,579$43.0K<0.1%00.0%UnchangedHolders
Q2 202243,579$53.0K<0.1%+15,954+57.8%AddedHolders
Q1 202227,625$41.0K<0.1%−3,750−12.0%ReducedHolders
Q4 202131,375$62.0K<0.1%+5,500+21.3%AddedHolders
Q3 202125,875$43.0K<0.1%00.0%UnchangedHolders
Q2 202125,875$48.0K<0.1%+9,250+55.6%AddedHolders
Q1 202116,625$28.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.